Join the Harlem Biospace member companies and attorneys from our flagship partner WilmerHale for the third in a series of workshops on legal topics relevant to biotech ventures. This session is focused on fundraising through convertible debt, what it is and when it can be a better option than equity. We will explore how to recognize when such funding is appropriate to pursue and define important considerations for structuring a deal.

WilmerHale Partner Jennifer Berrent will lead the discussion and Senior Associate Jared DeMatteis will also participate.